IMDX Stock Analysis: Buy, Sell, or Hold?
IMDX - Insight Molecular Diagnostics Inc. Common Stock
$6.41
1.31 (25.69%)
▲
5d:
+29.23%
30d:
+87.43%
90d:
+14.87%
WAIT
LOW Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Smart Money Distribution
IMDX is up 22.0% this week, but smart money is buying puts. Top strike: $4 2026-06-18 with 755 OI. Put ratio: 93% View Scanner →
Strength: 10.0/10
Get Alerted When IMDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: IMDX is 31.1% above its trading range ($4.89). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: IMDX is 31.1% above its trading range ($4.89). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: IMDX is currently trading at $6.41, which is considered extended relative to its 30-day fair value range of $3.26 to $4.89.
Technical Outlook: Technically, IMDX is in a strong downtrend. The price is approaching resistance at $5.60. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 25.7% recently.
Market Sentiment: IMDX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $8.33 (+63.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IMDX is in a strong downtrend. The price is approaching resistance at $5.60. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 25.7% recently.
Market Sentiment: IMDX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $8.33 (+63.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.26 -
$4.89
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price significantly overextended (+31.1% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+25.7%)
- BULLISH: Trading 63.4% below Wall St target ($8.33)
- WARNING: Recommendation downgraded due to 31.1% overvaluation
Trading Range Analysis
30-Day Trading Range
$3.26 -
$4.89
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$1.02
(16.0%)
Support & Resistance Levels
Support Level
$3.87
Resistance Level
$5.60
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.88
Wall Street Target
$8.33
(+63.4%)
Revenue Growth (YoY)
-23.4%
Share & Embed Analysis
Last updated: May 14, 2026 3:40 PM ET
Data refreshes hourly during market hours. Next update: 4:40 PM
Data refreshes hourly during market hours. Next update: 4:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMDX showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Broadwood Partners, L.P.
BUY
40690 shares
2026-04-20
Broadwood Partners, L.P.
BUY
40114 shares
2026-04-17
Broadwood Partners, L.P.
BUY
102057 shares
2026-04-16
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$620 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$250 | 58 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$130 | 59 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 58 HOLD |